Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Adamas Pharmaceuticals Inc (0001328143)
Standardized SEC financial data for Adamas Pharmaceuticals Inc — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001328143 · Pharmaceutical Preparations.
Gross margin
97.3%
Operating margin
-59.3%
Net margin
-77.1%
Revenue growth (YoY)
36.3%
Return on equity
114.9%
Free cash flow
-$50.7M
Debt / equity
-2.60×
Current ratio
3.21×
Ratios for fiscal year 2020, standardized from SEC filings.